Company Filing History:
Years Active: 2013-2015
Title: Lavinia Diana Cicortas Gunnarsson: Innovator in Antibody Research
Introduction
Lavinia Diana Cicortas Gunnarsson is a prominent inventor based in Oslo, Norway. She has made significant contributions to the field of antibody research, holding a total of 4 patents. Her work focuses on the development of antibodies that have important applications in medical and diagnostic fields.
Latest Patents
Among her latest patents, Lavinia has developed antibodies that bind to an epitope in the extracellular domain of human CC chemokine receptor 4 (CCR4). These antibodies are capable of inhibiting the binding of macrophage-derived chemokine (MDC) and/or thymus and activation regulated chemokine (TARC) to CCR4. Additionally, her patents include immunoconjugates and compositions comprising such antibodies, which are particularly useful in various medical and diagnostic applications.
Career Highlights
Lavinia is currently associated with Affitech Research AS, where she continues to advance her research in antibody development. Her innovative work has positioned her as a key figure in the field, contributing to the understanding and treatment of various medical conditions.
Collaborations
Lavinia has collaborated with notable colleagues, including Didrik Paus and Jenny Margareta Karlsson. These collaborations have further enriched her research and expanded the impact of her inventions.
Conclusion
Lavinia Diana Cicortas Gunnarsson is a distinguished inventor whose work in antibody research is paving the way for advancements in medical diagnostics and treatments. Her contributions are invaluable to the scientific community and hold promise for future innovations.